N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine
C27H24F2N6 — CID 164612777
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine
N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine (PubChem CID 164612777) has the molecular formula C27H24F2N6 and a molecular weight of 470.53 g/mol. Its IUPAC name is N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine.
Molecular Properties
| Compound Name | N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine |
|---|---|
| PubChem CID | 164612777 |
| Molecular Formula | C27H24F2N6 |
| Molecular Weight | 470.53 g/mol |
| Exact Mass | 470.20 |
| IUPAC Name | N-[2-(2,5-difluorophenyl)-4-pyridinyl]-7-[1-[2-(dimethylamino)ethyl]pyrazol-4-yl]quinolin-4-amine |
| SMILES | CN(C)CCn1cc(-c2ccc3c(Nc4ccnc(-c5cc(F)ccc5F)c4)ccnc3c2)cn1 |
| InChI | InChI=1S/C27H24F2N6/c1-34(2)11-12-35-17-19(16-32-35)18-3-5-22-25(8-10-31-26(22)13-18)33-21-7-9-30-27(15-21)23-14-20(28)4-6-24(23)29/h3-10,13-17H,11-12H2,1-2H3,(H,30,31,33) |
| InChIKey | MPUBMJCSEANNKB-UHFFFAOYSA-N |
| XLogP | 5.74 |
| TPSA | 58.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.53 |
| LogP ≤ 5 | 5.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 164612777 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.